Table 2.
Clinical Outcome
| All patients (N=13) | |
|---|---|
| Best response on lenvatinib (N) | |
| Complete response | 0 |
| Partial response | 4 |
| Stable disease | 4 |
| Progressive disease | 1 |
| not evaluable | 4 |
| Duration of lenvatinib treatment (months) - median (range) | 5 (1-18+) |
| Ongoing (N) | 6 |
| Terminated (N) | 7 |